Anti-Reflux Infant Formula Market Global Report 2026

The anti-reflux infant formula market size has grown strongly in recent years. It will grow from $74.24 billion in 2025 to $81.58 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of infant gastroesophageal reflux cases, increasing awareness regarding infant digestive disorders, growth in infant nutrition product adoption, increasing recommendations from pediatric healthcare professionals, rising demand for specialty infant formulas.

The anti-reflux infant formula market size is expected to see strong growth in the next few years. It will grow to $117.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing development of clinically advanced infant formulas, rising demand for customized nutritional solutions, growing focus on infant gut health management, expansion of premium pediatric nutrition products, increasing investment in specialized infant healthcare products. Major trends in the forecast period include increasing demand for clinically formulated anti-reflux nutrition products, rising preference for hydrolyzed and easy-to-digest ingredients, growing use of specialty formulas for infant digestive health management, increasing adoption of medically supervised infant nutrition solutions, expansion of allergy-specific and reflux-focused infant formulations.

The increasing number of infants is expected to drive the growth of the anti-reflux infant formula market going forward. An infant refers to a child from birth to approximately one year of age who relies on caregivers for essential needs and early development. The infant population is growing due to rising birth rates supported by improved healthcare access and enhanced living conditions. Anti-reflux infant formula helps infants by improving feed retention, reducing regurgitation, and supporting better nutrient absorption. For instance, in July 2025, according to the Office for National Statistics Census, a UK-based government agency, England and Wales recorded 594,677 live births in 2024, representing an increase of 3,605 births (0.6%) compared with 591,072 live births in 2023. Therefore, the increasing number of infants is driving the growth of the anti-reflux infant formula market.

The growing number of working mothers is expected to drive the growth of the anti-reflux infant formula market going forward. Working mothers are women with children who participate in paid employment while managing both childcare and professional responsibilities. The number of working mothers is increasing primarily due to rising living expenses, which encourage households to rely on dual incomes to meet financial requirements. Anti-reflux infant formula assists working mothers by minimizing infants’ spit-up and feeding-related discomfort, making feeding routines more manageable and consistent during demanding work schedules. For instance, in April 2024, according to the Bureau of Labor Statistics, a US-based government agency, 74% of mothers with children under the age of 18 were part of the workforce in 2023, reflecting a 1.1 percentage point increase from the previous year. Therefore, the growing number of working mothers is driving the growth of the anti-reflux infant formula market.

The increase in household incomes is expected to drive the growth of the anti-reflux infant formula market going forward. Household income refers to the total earnings received by all members of a household from various sources over a specific period, typically one year. Household incomes are increasing mainly due to expanding employment opportunities and wage growth, as industrial development and demand for skilled workers enable more individuals to earn higher salaries and additional income streams. Rising household incomes encourage the adoption of anti-reflux infant formula as families have greater purchasing power to invest in specialized and premium infant nutrition products, which are generally more costly than standard formulas, helping manage infant feeding challenges such as reflux. For instance, in October 2024, according to Statistics Iceland, an Iceland-based government agency, household disposable income increased by 6.6% in the second quarter of 2024 compared with the same period in the previous year. Therefore, increasing household incomes are driving the growth of the anti-reflux infant formula market.

Major companies operating in the anti-reflux infant formula market report are Humana GmbH, Nestlé SA, Abbott Laboratories, Danone SA, Reckitt Benckiser Group plc, Royal FrieslandCampina NV, Perrigo Company plc, The Hain Celestial Group Inc, Hero Group AG, HiPP GmbH & Co Vertrieb KG, Richen Nutritional Technology Co Ltd, Kendal Nutricare Ltd, Laboratorios Ordesa SL, Geo-Poland Sp z oo, Fasska Sp z oo, Lactalis Nutrition Santé SAS, Medical Brands Innovations BV, Laboratorios Basi, Sanulac Nutritionals BV, Bellamy's Organic, Bubs Australia, Nannycare.

North America was the dominating region in the anti-reflux infant formula market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the anti-reflux infant formula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti-reflux infant formula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.